Product
AK120
4 clinical trials
2 indications
Indication
Atopic DermatitisIndication
AsthmaClinical trial
a Multicenter, Randomized, Open Label Phase II Clinical Study to Evaluate the Safety and Efficacy of AK120 in the Treatment of Subjects With Moderate to Severe Atopic DermatitisStatus: Not yet recruiting, Estimated PCD: 2024-10-19
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of AK120 in the Treatment of Subjects With Moderate-to-severe AsthmaStatus: Terminated, Estimated PCD: 2022-08-05
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase Ib/II Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AK120 in the Treatment of Subjects With Moderate to Severe Atopic DermatitisStatus: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
a Randomized Double-blind, Placebo-controlled, Multicenter Phase III Clinical Study to Evaluate the Efficacy and Safety of AK120 in the Treatment of Patients With Moderate to Severe Atopic DermatitisStatus: Recruiting, Estimated PCD: 2025-01-30